Novartis’ new heart failure medicine Sacubitril valsartan is now available in the UK Sacubitril valsartan (Entresto™) is now available for UK adults with symptomatic chronic heart failure with reduced ejection fraction Largest heart failure study showed Entresto (sacubitril valsartan) saves lives and reduces hospitalisation for people with heart failure when compared to enalapril, an ACE-inhibitor, and […]

£3-a-day heart failure drug Sacubitril valsartan, described as biggest breakthrough in 15 years after reducing death rates by 20%, available tomorrow and on NHS from May Breakthrough heart failure drug Sacubitril valsartan to be made available to private patients from tomorrow The breakthrough drug is expected to be available from the NHS by May 2016 Clnical […]

Scientists have discovered a way to stimulate muscle cell growth in the heart, limiting the damage to this vital organ after a heart attack. It’s hoped this exciting research, where scientists discover how to stimulate heart muscle cell growth (within the theart), which was conducted by Professor Eldad Tzahor from the Weizmann Institute of Science […]